Guang-Jer Wu

5PUBLICATIONS
2CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersMedical virologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 24, 2025
METCAM/MUC18 is a Biomarker and Therapeutic Target for Prostate Cancer.

Guang-Jer Wu, Chia-Chi Hsieh, Yan-Cheng Fu

|Jan 21, 2023
METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer.

Jui-Chuang Wu, Guang-Jer Wu

|Nov 11, 2022
METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I.

Yen-Chun Liu, Yu-Jen Chen, Guang-Jer Wu

|Apr 03, 2021
Validating METCAM/MUC18 as a Novel Biomarker to Predict the Malignant Potential of Prostate Cancer at an Early Stage by Using a Modified Gold Nanoparticles-Based Lateral Flow Immunoassay.

Jui-Chuang Wu, Yin-Huan Chuang, Yu-Chun Wei

|Oct 03, 2018
METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells.

Guang-Jer Wu

Pageof 1

Frequent Collaborators

1 joint publications

Yuan-Hung Pong

1 joint publications

Yu-Jen Chen